The recent evolution of the Biotech local innovation system of Minas Gerais: university local firms and transnational corporations
1. The Evolution of the Biotech Innovation System of Minas Gerais
During the last decade, the Brazilian private biotechnology sector has quickly expanded. In 1993, there were 76 biotechnology firms in Brazil; by 2001, their number had increased to 354. Approximately 70% are local private firms, 25% are multinational and 5% are state-owned firms. Of their combined products, 26% are for the health care market and the rest are for agricultural, environmental and industrial fields.
Health biotech evolved in Brazil through a combination of high scientific capacity and policies geared towards fostering spin-off firms from university research. One of the most interesting experiences happened in the Southeast State of Minas Gerais. Belo Horizonte, the capital of Minas Gerais State, has played an active role in building up biotech capability in Brazil. By 2000 the city hosted thirty-five biotech firms located in both its urban metropolitan area and smaller regional cities of Minas Gerais, as shown in Table 1. (more…)